The case involves a petition filed by Export-Import Bank of India, Bank of India (New York Branch), State Bank of India, and Union Bank of India to initiate Corporate Insolvency Resolution Process (CIRP) against Maneesh Pharmaceuticals Limited under Section 7 of the Insolvency and Bankruptcy Code, 2016, due to alleged default in repayment of debt. The Corporate Debtor's foreign subsidiary, Svizera Holdings B.V., defaulted on a term loan facility of USD 45 million. The Corporate Debtor had provided a corporate guarantee. The account was classified as NPA by various banks in 2011. Barclays Bank PLC, Hong Kong, issued an Acceleration Notice in 2012. A foreign suit was filed in Queen's Bench, UK, resulting in a judgment against the Corporate Debtor in 2014. The Corporate
…M/s Svizera Holdings B.V., a foreign subsidiary of Maneesh Pharmaceuticals Limited, obtained a term loan facility of USD 45 million from Export-Import Bank of India, Bank of India (New York Branch), State Bank of India, and Union Bank of India. Maneesh Pharmaceuticals Limited provided a corporate guarantee for the loan. The Borrower defaulted on the loan, leading to the account being classified as a Non-Performing Asset (NPA) by the banks in 2011. Barclays Bank PLC, Hong Kong, issued an Acceleration Notice in 2012. The Facility Agent filed a suit against the Borrower and Corporate Debtor in the Queen's Bench Division, Commercial Court, London, which resulted in a judgment dated 08.04.2014 directing the Corporate Debtor to pay USD 35,355,064.80. The Corporate Debtor
…Sign in to view the parties.
Financial Creditors extended a term loan…
The loan amount was…
The case involves a petition filed by Export-Import Bank of India, Bank of India (New York Branch), State Bank of India, and Union Bank of India to initiate Corporate Insolvency Resolution Process (CIRP) against Maneesh Pharmaceuticals Limited under Section 7 of the Insolvency and Bankruptcy Code, 2016, due to alleged default in repayment of debt. The Corporate Debtor's foreign subsidiary, Svizera Holdings B.V., defaulted on a term loan facility of USD 45 million. The Corporate Debtor had provided a corporate guarantee. The account was classified as NPA by various banks in 2011. Barclays Bank PLC, Hong Kong, issued an Acceleration Notice in 2012. A foreign suit was filed in Queen's Bench, UK, resulting in a judgment against the Corporate Debtor in 2014. The Corporate
…M/s Svizera Holdings B.V., a foreign subsidiary of Maneesh Pharmaceuticals Limited, obtained a term loan facility of USD 45 million from Export-Import Bank of India, Bank of India (New York Branch), State Bank of India, and Union Bank of India. Maneesh Pharmaceuticals Limited provided a corporate guarantee for the loan. The Borrower defaulted on the loan, leading to the account being classified as a Non-Performing Asset (NPA) by the banks in 2011. Barclays Bank PLC, Hong Kong, issued an Acceleration Notice in 2012. The Facility Agent filed a suit against the Borrower and Corporate Debtor in the Queen's Bench Division, Commercial Court, London, which resulted in a judgment dated 08.04.2014 directing the Corporate Debtor to pay USD 35,355,064.80. The Corporate Debtor
…Financial Creditors extended a term loan…
The loan amount was…